Pathology data indicate 70% overall response rate for squamous cell carcinomas: 100% clearance in 10 out of 14 responders ...

Tumors of the middle ear and temporal bone are uncommon, and determining their primary site is often challenging. Due to their proximity to the skull base, nasopharynx, and paranasal sinuses, the ...

It Ends With Us author Colleen Hoover shared a promising health update after being diagnosed with cancer in 2025.

Hispanic patients show a lower risk and longer time to a second cutaneous squamous cell carcinoma than matched non-Hispanic ...

A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the ...

Onco360(R) , the nation's leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Sun Pharmaceuticals for UNLOXCYT(TM) (cosibelimab-ipdl). UNLOXCYT is the first ...

Real Housewives of Beverly Hills' Teddi Mellencamp said "everything’s good as it can be" amid her cancer battle after her ...

Real Housewives of Beverly Hills' Teddi Mellencamp said "everything’s good as it can be" amid her cancer battle after her ...

Nearly one-third of patients who responded to a survey did not understand common skin cancer terms frequently used by ...

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Sun ...

Cancer represents a key challenge in medical science, manifesting as a disease where the immune system fails to recognize and eliminate tumor cells. The phenomenon of immune evasion by cancer cells ...

BioNTech's gotistobart receives FDA orphan drug designation, showing promise in improving survival for patients with squamous ...